Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qlarivia is a Romanian life sciences company and brand specializing in the production and commercialization of deuterium-depleted water (DDW). The company's flagship product, Qlarivia, features a deuterium concentration of 25 parts per million (ppm), significantly lower than the 150 ppm found in standard water. Qlarivia markets its DDW as a wellness product and an adjuvant treatment for various health conditions, based on research suggesting that lower deuterium levels can influence cellular metabolism and DNA stability. The company operates in the intersection of biotechnology and consumer health, providing specialized hydration solutions for health-conscious consumers and patients undergoing clinical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qlarivia.